Focal Medical Receives FDA Clearance to Initiate Phase 1b Clinical Trial of ACT-IOP-003, a Targeted Therapeutic Product in Development for Pancreatic Cancer venturebeat.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from venturebeat.com Daily Mail and Mail on Sunday newspapers.
Raleigh medtech startup to use new funding for drug delivery system targeting pancreatic cancer wraltechwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wraltechwire.com Daily Mail and Mail on Sunday newspapers.
ACT Gets Funding for Pancreatic Cancer Treatment Device | North Carolina Biotechnology Center ncbiotech.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ncbiotech.org Daily Mail and Mail on Sunday newspapers.